BIIB vs ORMP
Biogen Inc (BIIB) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the BIIB and ORMP stock pages for the full models.
Not investment advice.